CAS 130209-82-4
:Latanoprost
Description:
Latanoprost is a synthetic prostaglandin analog primarily used in the treatment of glaucoma and ocular hypertension. It functions by increasing the outflow of aqueous humor, thereby reducing intraocular pressure. The substance is characterized by its ability to selectively bind to the prostaglandin F2α receptor, which plays a crucial role in its mechanism of action. Latanoprost is typically administered as an ophthalmic solution, and its formulation often includes preservatives to enhance stability and shelf life. The compound is known for its relatively high lipophilicity, allowing it to penetrate ocular tissues effectively. Common side effects may include eye redness, changes in iris pigmentation, and eyelash growth. Latanoprost is generally well-tolerated, but it is contraindicated in patients with a history of hypersensitivity to the drug or its components. Its pharmacokinetics involve rapid absorption and metabolism, with a half-life that supports once-daily dosing, making it a convenient option for patients managing chronic eye conditions.
Formula:C26H40O5
InChI:InChI=1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
InChI key:InChIKey=GGXICVAJURFBLW-CEYXHVGTSA-N
SMILES:C(/C=C\CCCC(OC(C)C)=O)[C@@H]1[C@@H](CC[C@H](CCC2=CC=CC=C2)O)[C@H](O)C[C@@H]1O
Synonyms:- 5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-, 1-methylethyl ester, [1R-[1α(Z),2β(R*),3α,5α]]-
- PhXA 41
- XA 41
- Latanoprost
- 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylethyl ester, (5Z)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 15 products.
Latanoprost
CAS:Formula:C26H40O5Purity:>98.0%(HPLC)Color and Shape:Colorless to Light yellow clear liquidMolecular weight:432.60Latanoprost
CAS:<p>Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analogues</p>Formula:C26H40O5Color and Shape:Yellow Liquid OilMolecular weight:432.287575-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylethyl ester, (5Z)-
CAS:Formula:C26H40O5Purity:97%Color and Shape:LiquidMolecular weight:432.5928Ref: IN-DA000U58
1gTo inquire5gTo inquire10gTo inquire10mg52.00€25mg75.00€50mg113.00€100mg152.00€250mg259.00€Latanoprost (0.10% wt/v in ETHANOL), min. 98%
CAS:Formula:C26H40O5Purity:min. 98%Color and Shape:Colorless to Yellowish Oil (SOLUTION IN 10% ETHANOL)Molecular weight:432.59Latanoprost
CAS:Formula:C26H40O5Purity:≥ 99.0%Color and Shape:Colourless to light yellow liquidMolecular weight:432.59Latanoprost
CAS:Controlled ProductFormula:C26H40O5Color and Shape:Light YellowMolecular weight:432.59Latanoprost
CAS:<p>Latanoprost (Xalatan) is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.</p>Formula:C26H40O5Purity:99.69% - 99.89%Color and Shape:Pale Yellow OilMolecular weight:432.59Latanoprost
CAS:<p>Applications Prostaglandin analog, used to treat glaucoma and other degenerative diseases of the eye.<br>References Rhee, D.J., et al.: Clinic. Ophthalmol., 2, 313 (2008), Hernandez, M., et al.: Exp. Eye Res., 86, 798 (2008), Nagata, T., et al.: J. Pharmacol. Sci., 106, 423 (2008), Ikeda, Y., et al.: J. Ocular Pharmacol. Ther., 24, 230 (2008),<br></p>Formula:C26H40O5Color and Shape:Light YellowMolecular weight:432.59Latanoprost
CAS:<p>Agonist of FP prostaglandin receptor, EP1 and EP3 prostaglandin receptors</p>Formula:C26H40O5Purity:Min. 98 Area-%Color and Shape:Clear LiquidMolecular weight:432.59 g/mol5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, 1-methylethyl ester, (5Z)-
CAS:Purity:99%Molecular weight:432.6010132














